Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Eastman Chemical (EMN) Hikes Prices Of Choline Chloride

Published 12/17/2018, 08:42 PM
Updated 07/09/2023, 06:31 AM

Eastman Chemical Company (NYSE:EMN) is raising prices of Choline Chloride effective Jan 1, 2019 or as contracts permit.

In North and Latin America, the company raises Choline Chloride, Feed Grade prices by 20 cents per lb and in Asia Pacific, by $50/MT. In Europe, Middle East and Africa (EMEA), the company is increasing prices of the same product by €45/MT.

Eastman Chemical is taking actions to hike selling prices of these products in the wake of higher operating costs.

Higher selling prices of most product lines contributed to revenue growth at the company’s Additives & Functional Products and Chemical Intermediates segments in the third quarter of 2018.

In a year’s time, shares of Eastman Chemical have outperformed the industry it belongs to. The stock has lost around 23.7% compared with the industry’s fall of 28%.


During third-quarter earnings call, Eastman Chemical noted that strong volume gains in the specialty businesses, disciplined cost management and a lower effective tax rate helped it achieve year-over-year adjusted earnings per share growth of 13% during the first nine months of 2018. The company continues to expect a year-over-year adjusted earnings per share rise of 10-14% for 2018. It also estimates to generate roughly $1.1 billion of free cash flow in 2018.

The company is focused on productivity and cost-cutting actions, which are aiding it to offset raw material cost inflation and other cost headwinds. In 2018, Eastman Chemical expects to deliver $100 million of savings under its cost-reduction program.

Eastman Chemical has been seeing a rise in raw materials costs, mostly in its chemical intermediates business as witnessed in the third quarter. Raw materials cost woe is anticipated to persist through the remainder of 2018. Nevertheless, the company’s productivity and price-hike actions are likely to enable it to offset the input cost pressure.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Eastman Chemical Company Price and Consensus

Zacks Rank & Stocks to Consider

Eastman Chemical currently carries a Zacks Rank #3 (Hold). A few better-ranked stocks in the basic materials space are CF Industries Holdings, Inc. (NYSE:CF) , The Mosaic Company (NYSE:MOS) and Cameco Corporation (NYSE:CCJ) .

CF Industries has an expected earnings growth rate of 748% for the current year and a Zacks Rank #1 (Strong Buy). The stock has inched up 0.5% in the past year. You can see the complete list of today’s Zacks #1 Rank stocks here.

Mosaic has an expected earnings growth rate of 75.2% for the current year and a Zacks Rank #2 (Buy). The company’s shares have rallied 22.8% in the past year.

Cameco has an expected earnings growth rate of 66.7% for the current year and a Zacks Rank #2. Its shares have gained 11.8% in a year’s time.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>



Eastman Chemical Company (EMN): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

CF Industries Holdings, Inc. (CF): Free Stock Analysis Report

The Mosaic Company (MOS): Free Stock Analysis Report

Cameco Corporation (CCJ): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.